Daniel E. Furst

The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials

J J Anderson, P. Tugwell, C. Bombardier, 1993 .

Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials

D. Furst, P. Emery, E. Keystone, 2010 .

Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor α antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study

E. Keystone, P. Mease, P. Anklesaria, 2008, Annals of the rheumatic diseases.

American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

Raveendhara R. Bannuru, E. Akl, J. Singh, 2015 .

Updating the OMERACT Filter: Core Areas as a Basis for Defining Core

P. Tugwell, M. Dougados, D. Beaton, 2014 .

Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains.

P. Tugwell, D. Gladman, C. Gordon, 1999, The Journal of rheumatology.